MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer

A large proportion of anti-tumor immunity research is focused on major histocompatibility complex class I (MHC-I) molecules and CD8(+) T cells. Despite mounting evidence has shown that CD4(+) T cells play a major role in anti-tumor immunity, the role of the MHC-II molecules in tumor immunotherapy ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Ruibin, Hong, Shuo, Zhang, Yueming, Lin, Anqi, Ying, Haoxuan, Zou, Weidong, Wang, Qiongyao, Wei, Ting, Cheng, Quan, Zhu, Weiliang, Luo, Peng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873787/
https://www.ncbi.nlm.nih.gov/pubmed/35223828
http://dx.doi.org/10.3389/fcell.2022.757137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873787/
https://www.ncbi.nlm.nih.gov/pubmed/35223828
http://dx.doi.org/10.3389/fcell.2022.757137

Ejemplares similares